XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Arcadia Wellness [Member]
January 2021 PIPE [Member]
Common Stock [Member]
Common Stock [Member]
Arcadia Wellness [Member]
Common Stock [Member]
January 2021 PIPE [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Arcadia Wellness [Member]
Additional Paid-In Capital [Member]
January 2021 PIPE [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Non-Controlling Interest [Member]
Stockholders Equity, Beginning Balance at Dec. 31, 2020 $ 28,552     $ 54     $ 239,496     $ (211,825)   $ 827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Issuance of shares     $ 15,516     $ 8     $ 15,508      
Issuance of shares, Shares           7,876,784            
Offering costs     (2,084)           (2,084)      
Issuance of placement agent warrants     $ 942           $ 942      
Issuance of shares related to employee stock purchase plan 21           21          
Issuance of shares related to employee stock purchase plan, Shares       8,604                
Stock-based compensation 325           325          
Non-controlling interest contributions 750                     750
Net income (loss) 1,681                 2,058   (377)
Stockholders Equity, Ending Balance at Mar. 31, 2021 45,703     $ 62     254,208     (209,767)   1,200
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2021       21,336,249                
Stockholders Equity, Beginning Balance at Dec. 31, 2020 28,552     $ 54     239,496     (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Foreign currency translation adjustment (12)                      
Net income (loss) (3,740)                      
Stockholders Equity, Ending Balance at Jun. 30, 2021 42,678     $ 63     256,616     (215,028) $ (12) 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021       22,163,650                
Stockholders Equity, Beginning Balance at Dec. 31, 2020 $ 28,552     $ 54     239,496     (211,825)   827
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2020       13,450,861                
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                      
Net income (loss) $ (16,100)                      
Stockholders Equity, Ending Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Ending Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392           19,390     (15,998)    
Stockholders Equity, Ending Balance, Shares at Dec. 31, 2021       22,184,235                
Stockholders Equity, Beginning Balance at Mar. 31, 2021 45,703     $ 62     254,208     (209,767)   1,200
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2021       21,336,249                
Issuance of common stock at closing of acquisition transaction   $ 2,053     $ 1     $ 2,052        
Issuance of common stock at closing of acquisition transaction, Shares         827,401              
Foreign currency translation adjustment (12)                   (12)  
Stock-based compensation 356           356          
Net income (loss) (5,422)                 (5,261)   (161)
Stockholders Equity, Ending Balance at Jun. 30, 2021 42,678     $ 63     256,616     (215,028) $ (12) 1,039
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2021       22,163,650                
Stockholders Equity, Beginning Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021       22,184,235                
Issuance of shares related to employee stock purchase plan 4           4          
Issuance of shares related to employee stock purchase plan, Shares       4,683                
Stock-based compensation 260           260          
Net income (loss) (4,610)                 (4,488)   (122)
Stockholders Equity, Ending Balance at Mar. 31, 2022 30,242     $ 63     277,169     (246,971)   (19)
Stockholders Equity, Ending Balance, Shares at Mar. 31, 2022       22,188,918                
Stockholders Equity, Beginning Balance at Dec. 31, 2021 31,196     $ 63     257,515     (226,485)   103
Stockholders Equity, Beginning Balance (Accounting Standards Update 2020-06 [Member]) at Dec. 31, 2021 3,392           19,390     (15,998)    
Stockholders Equity, Beginning Balance, Shares at Dec. 31, 2021       22,184,235                
Net income (loss) (8,407)                      
Stockholders Equity, Ending Balance at Jun. 30, 2022 26,768     $ 63     277,492     (250,748)   (39)
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2022       22,188,918                
Stockholders Equity, Beginning Balance at Mar. 31, 2022 30,242     $ 63     277,169     (246,971)   (19)
Stockholders Equity, Beginning Balance, Shares at Mar. 31, 2022       22,188,918                
Stock-based compensation 323           323          
Net income (loss) (3,797)                 (3,777)   (20)
Stockholders Equity, Ending Balance at Jun. 30, 2022 $ 26,768     $ 63     $ 277,492     $ (250,748)   $ (39)
Stockholders Equity, Ending Balance, Shares at Jun. 30, 2022       22,188,918